CUBE vs ZYME
CubeSmart (CUBE) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the CUBE and ZYME stock pages for the full models.
Not investment advice.